Drug profile · INN
coronavirus (sars-cov-2) rna vaccine
DAICHIRONA PARTIAL CHANGE APPROVAL
- Patents linked
- 0
- News articles
- 0
Quick answer
coronavirus (sars-cov-2) rna vaccine (DAICHIRONA PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN coronavirus (sars-cov-2) rna vaccine
Brand DAICHIRONA PARTIAL CHANGE APPROVAL
Frequently asked questions
What is coronavirus (sars-cov-2) rna vaccine?
coronavirus (sars-cov-2) rna vaccine (DAICHIRONA PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for coronavirus (sars-cov-2) rna vaccine?
DAICHIRONA PARTIAL CHANGE APPROVAL is a marketed brand name for coronavirus (sars-cov-2) rna vaccine. Check FDA Drugs@FDA for the current US label holder and prescribing information.